Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 158

Similar articles for PubMed (Select 23200084)

1.

Modulation of attention network activation under antidepressant agents in healthy subjects.

Graf H, Abler B, Hartmann A, Metzger CD, Walter M.

Int J Neuropsychopharmacol. 2013 Jul;16(6):1219-30. doi: 10.1017/S1461145712001368. Epub 2012 Dec 3.

PMID:
23200084
2.

Neural correlates of antidepressant-related sexual dysfunction: a placebo-controlled fMRI study on healthy males under subchronic paroxetine and bupropion.

Abler B, Seeringer A, Hartmann A, Grön G, Metzger C, Walter M, Stingl J.

Neuropsychopharmacology. 2011 Aug;36(9):1837-47. doi: 10.1038/npp.2011.66. Epub 2011 May 4.

3.

Effect of bupropion extended release on negative emotion processing in major depressive disorder: a pilot functional magnetic resonance imaging study.

Robertson B, Wang L, Diaz MT, Aiello M, Gersing K, Beyer J, Mukundan S Jr, McCarthy G, Doraiswamy PM.

J Clin Psychiatry. 2007 Feb;68(2):261-7.

PMID:
17335325
4.

Subchronic SSRI administration reduces insula response during affective anticipation in healthy volunteers.

Simmons AN, Arce E, Lovero KL, Stein MB, Paulus MP.

Int J Neuropsychopharmacol. 2009 Sep;12(8):1009-20. doi: 10.1017/S1461145709990149. Epub 2009 Jun 23.

5.

Serotonergic and noradrenergic modulation of emotion processing by single dose antidepressants.

Brühl AB, Kaffenberger T, Herwig U.

Neuropsychopharmacology. 2010 Jan;35(2):521-33. doi: 10.1038/npp.2009.159. Epub .

6.

Effects of the cholinergic agonist nicotine on reorienting of visual spatial attention and top-down attentional control.

Thiel CM, Fink GR.

Neuroscience. 2008 Mar 18;152(2):381-90. doi: 10.1016/j.neuroscience.2007.10.061. Epub 2008 Jan 8.

PMID:
18272290
7.

SSRI-related modulation of sexual functioning is predicted by pre-treatment resting state functional connectivity in healthy men.

Metzger CD, Walter M, Graf H, Abler B.

Arch Sex Behav. 2013 Aug;42(6):935-47. doi: 10.1007/s10508-013-0103-3. Epub 2013 Jun 15.

PMID:
23771550
8.

Differential modulation of emotion processing brain regions by noradrenergic and serotonergic antidepressants.

Brühl AB, Jäncke L, Herwig U.

Psychopharmacology (Berl). 2011 Aug;216(3):389-99. doi: 10.1007/s00213-011-2227-2. Epub 2011 Feb 26.

PMID:
21359508
9.

Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer.

Loubinoux I, Tombari D, Pariente J, Gerdelat-Mas A, Franceries X, Cassol E, Rascol O, Pastor J, Chollet F.

Neuroimage. 2005 Aug 15;27(2):299-313.

PMID:
15950492
10.

The effects of reboxetine on emotional processing in healthy volunteers: an fMRI study.

Norbury R, Mackay CE, Cowen PJ, Goodwin GM, Harmer CJ.

Mol Psychiatry. 2008 Nov;13(11):1011-20. Epub 2007 Oct 23.

PMID:
17955021
11.

Modulation of frontostriatal interaction aligns with reduced primary reward processing under serotonergic drugs.

Abler B, Grön G, Hartmann A, Metzger C, Walter M.

J Neurosci. 2012 Jan 25;32(4):1329-35. doi: 10.1523/JNEUROSCI.5826-11.2012.

12.

A single dose of the serotonin neurotransmission agonist paroxetine enhances motor output: double-blind, placebo-controlled, fMRI study in healthy subjects.

Loubinoux I, Pariente J, Boulanouar K, Carel C, Manelfe C, Rascol O, Celsis P, Chollet F.

Neuroimage. 2002 Jan;15(1):26-36.

PMID:
11771971
13.

Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study.

Miskowiak KW, Favaron E, Hafizi S, Inkster B, Goodwin GM, Cowen PJ, Harmer CJ.

Psychopharmacology (Berl). 2009 Nov;207(1):133-42. doi: 10.1007/s00213-009-1641-1. Epub 2009 Aug 25.

PMID:
19705104
14.

Neurocognitive effects of HF-rTMS over the dorsolateral prefrontal cortex on the attentional processing of emotional information in healthy women: an event-related fMRI study.

De Raedt R, Leyman L, Baeken C, Van Schuerbeek P, Luypaert R, Vanderhasselt MA, Dannlowski U.

Biol Psychol. 2010 Dec;85(3):487-95. doi: 10.1016/j.biopsycho.2010.09.015. Epub 2010 Oct 12.

PMID:
20923694
15.

Human brain functional network changes associated with enhanced and impaired attentional task performance.

Giessing C, Thiel CM, Alexander-Bloch AF, Patel AX, Bullmore ET.

J Neurosci. 2013 Apr 3;33(14):5903-14. doi: 10.1523/JNEUROSCI.4854-12.2013.

16.

Direction and magnitude of nicotine effects on the fMRI BOLD response are related to nicotine effects on behavioral performance.

Warbrick T, Mobascher A, Brinkmeyer J, Musso F, Stoecker T, Shah NJ, Vossel S, Winterer G.

Psychopharmacology (Berl). 2011 May;215(2):333-44. doi: 10.1007/s00213-010-2145-8. Epub 2011 Jan 18.

17.

Differential effects of amitriptyline, nefazodone and paroxetine on performance and brain indices of visual selective attention and working memory.

van Laar MW, Volkerts ER, Verbaten MN, Trooster S, van Megen HJ, Kenemans JL.

Psychopharmacology (Berl). 2002 Aug;162(4):351-63. Epub 2002 Jun 5.

PMID:
12172688
18.

The role of 5-HT in response inhibition and re-engagement.

Drueke B, Schlaegel SM, Seifert A, Moeller O, Gründer G, Gauggel S, Boecker M.

Eur Neuropsychopharmacol. 2013 Aug;23(8):830-41. doi: 10.1016/j.euroneuro.2013.05.005. Epub 2013 Jun 29.

PMID:
23816061
19.

Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study.

Windischberger C, Lanzenberger R, Holik A, Spindelegger C, Stein P, Moser U, Gerstl F, Fink M, Moser E, Kasper S.

Neuroimage. 2010 Jan 15;49(2):1161-70. doi: 10.1016/j.neuroimage.2009.10.013. Epub 2009 Oct 13.

PMID:
19833214
20.

Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man.

Schmitt JA, Ramaekers JG, Kruizinga MJ, van Boxtel MP, Vuurman EF, Riedel WJ.

J Psychopharmacol. 2002 Sep;16(3):207-14.

PMID:
12236626
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk